+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
From
Biologic Therapeutic Drugs: Technologies and Global Markets - Product Thumbnail Image

Biologic Therapeutic Drugs: Technologies and Global Markets

  • Report
  • January 2024
  • 253 Pages
  • Global
From
The World Market for Vaccines, 2024 - Product Thumbnail Image

The World Market for Vaccines, 2024

  • Report
  • February 2024
  • 202 Pages
  • Global
From
From
Glaucoma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Glaucoma Therapeutics - Global Strategic Business Report

  • Report
  • November 2024
  • 193 Pages
  • Global
From
From
Cathepsin K/S Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cathepsin K/S Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Cathepsin K Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Cathepsin K Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Uveal Melanoma - Pipeline Insight, 2024 - Product Thumbnail Image

Uveal Melanoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 90 Pages
  • Global
From
Loading Indicator